Get the Stockscreener App
57.42
3.84%
-2.29
After Hours:
57.55
0.13
+0.23%
Overview
News
Price History
Option Chain
Financials
Why BMY Down?
Discussions
Forecast
Stock Split
Dividend History
Bristol Myers Squibb Co Stock (BMY) Latest News
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Jennison Associates LLC - MarketBeat
McAdam LLC Raises Stock Position in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
Why This Drug Titan Tumbled Despite Its Earnings Beat - Investor's Business Daily
Bristol Myers Squibb kicks off $2B cost-cutting campaign - NJBIZ
Bristol Myers Squibb (BMY) Q4 2024 Earnings Call Transcript - AOL
Jim Cramer on Bristol-Myers Squibb (BMY): “First Schizophrenia Drug in 30 Years” - Insider Monkey
Dow Dips 150 Points; Bristol Myers Squibb Issues Weak Outlook - Benzinga
Bristol Myers Squibb Warns Near-Term Impact Due To Generics On 2025 Sales Forecast, Outlines $2 Billion In Additional Cost Cuts - AOL
Idiopathic Membranous Nephropathy Market Expected to rise, 2034 | Bristol Myers Squibb Company, Merck and Co Inc., Mylan Pharmaceutical ltd., Novartis AG, Pfizer Inc., Roche, Aspen Global Inc., Astell - Barchart
Bristol Myers gives first peek at closely watched launch of schizophrenia drug - BioPharma Dive
Bristol-Myers Squibb Loses Ground on Announcing Cost Cuts - Baystreet.ca
Bristol Myers forecasts steeper drop in 2025 revenue, shares fall - Yahoo Canada Finance
Earnings call transcript: Bristol-Myers Squibb Q4 2024 beats estimates - Investing.com
Bristol-Myers Squibb Co (BMY) Q4 Earnings: Revenue Surpasses Est - GuruFocus.com
Bristol Myers Squibb Tops Q4 Estimates - The Motley Fool
Bristol Myers Squibb delivers solid Q4 performance, FY25 guidance disappoints - ShareCast
Bristol Myers Wallops Fourth-Quarter Earnings Views. But Shares Plummet 5%. - Yahoo! Voices
Bristol Myers Squibb, amid restructuring, unveils plan to cut another $2B in costs - FiercePharma
Bristol Myers Earnings Are a ‘Tale of 2 Trends’ as Guidance Falls Short. The Stock Is Falling - Yahoo! Voices
Bristol-Myers Squibb Reports Strong Q4 2024 Financial Results - TipRanks
BMS extends its cost-cutting drive by another $2bn - pharmaphorum
Bristol-Myers Squibb (NYSE:BMY) Posts Better-Than-Expected Sales In Q4 But Full-Year Sales Guidance Misses Expectations By Stock Story - Investing.com Canada
Idiopathic Membranous Nephropathy Market Expected to rise, - openPR
Bristol Myers misses expectations for 2025 guidance, shares fall By Investing.com - Investing.com Canada
Bristol Myers: Q4 Earnings Snapshot -February 06, 2025 at 07:23 am EST - Marketscreener.com
Bristol Myers misses expectations for 2025 guidance, shares fall - Investing.com
Bristol Myers Squibb Surprises With Earnings Despite Competitive Challenges - Finimize
Bristol Myers forecasts steeper drop in 2025 revenue, shares fall By Reuters - Investing.com
Bristol-Myers Squibb earnings beat by $0.20, revenue topped estimates - Investing.com India
Bristol Adds to Cost Cutting With Outlook Missing Estimates - Bloomberg
Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance - CNBC
Bristol-Myers Squibb Q4 24 Earnings Conference Call At 8:00 AM ET - Nasdaq
Bristol-Myers Squibb, Amazon And 3 Stocks To Watch Heading Into Thursday - Benzinga
Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q4 Results Tomorrow - Barchart
Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q4 Results Tomorrow By Stock Story - Investing.com Canada
Bristol Myers Squibb call volume above normal and directionally bullish - TipRanks
Is Bristol-Myers Squibb Company (BMY) the Best Wide Moat Stock to Invest In? - Insider Monkey
Bristol-Myers Squibb's SWOT analysis: stock outlook mixed amid pipeline progress - MSN
Mirae Asset Global Investments Co. Ltd. Boosts Stake in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by CENTRAL TRUST Co - MarketBeat
Inlet Private Wealth LLC Has $2.71 Million Position in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Bristol Myers Squibb, Kyowa Kirin layoffs hit 119 in New Jersey amid separate restructuring campaigns - FiercePharma
Cantor Fitzgerald lifts Bristol-Myers price target to $55 - Investing.com
Greenwood Capital Associates LLC Sells 4,698 Shares of Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
The Zacks Analyst Blog Highlights Merck, Pfizer, Eli Lilly, Amgen And Bristol Myers Squibb - Barchart
The Zacks Analyst Blog Highlights Merck, Pfizer, Eli Lilly, Amgen and Bristol Myers Squibb - Yahoo Finance
4,335 Shares in Bristol-Myers Squibb (NYSE:BMY) Purchased by Synergy Asset Management LLC - MarketBeat
BMY Gets Positive CHMP Opinion for Opdivo, Yervoy Combo and Breyanzi - Yahoo Finance
What Analyst Projections for Key Metrics Reveal About Bristol Myers (BMY) Q4 Earnings - MSN
Jim Cramer on Bristol-Myers Squibb Company (BMY): ‘With That Yield, It’s One Of My Faves’ - Insider Monkey
Should Bristol Myers Stock Be in Your Portfolio Pre-Q4 Earnings? - Nasdaq
KG&L Capital Management LLC Sells 15,435 Shares of Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
2 High-Yield Dividend Stocks to Hold Through 2025 and Beyond - The Motley Fool
FSM Wealth Advisors LLC Buys New Stake in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
Bristol-Myers Squibb (NYSE:BMY) Shares Acquired by Greenleaf Trust - MarketBeat
Milestone Asset Management LLC Purchases New Shares in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat
1.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):